François Roman

Title: François Roman: Patents in Drug Discovery and Treatment

Introduction

François Roman is an inventor associated with Vitry-sur-Seine, France. His patent work includes methods for screening calcium-channel modulators and a proposed use of trimebutine in treating pain and inflammatory conditions. The supplied information lists 2 patents and identifies Warner-Lambert Company as his company.

Latest Patents

Methods and Compositions for Screening Icrac Modulators. This invention describes compositions and methods for screening or characterizing compounds that affect calcium channels, particularly calcium-release-activated channels. The method exposes channel-expressing cells to a test compound and a channel activator, then assesses reporter-gene expression under the control of an NFAT-inducible promoter. The approach is intended to help identify channel inhibitors or activators that could serve as leads or candidate therapeutic drugs.

Method for Preventing and Treating Arthritis, Osteo-Traumatic Pain, and Neuralgias with Trimebutine. This patent concerns using trimebutine, or its corresponding stereoisomers, to prepare a medicament for preventing or treating arthritis, osteo-traumatic pain, and neuralgias.

Career Highlights

The available information connects Roman’s patent activity with Warner-Lambert Company. His listed inventions address both drug-discovery methods and potential therapeutic applications.

Collaborations

Gilles Brunelle and Janet Allen are identified as Roman’s coworkers. The supplied information does not specify their roles in the listed patents.

Conclusion

François Roman’s two listed patents reflect work spanning calcium-channel screening and proposed treatments for arthritis and pain-related conditions.